Frontline Treatment of ER-Positive Breast Cancer

preview_player
Показать описание
In this segment, panelists discuss the frontline treatment of postmenopausal patients with ER-positive, HER2-negative metastatic breast cancer.
  1. OncLive
  2. cancer
  3. oncology
  4. Breast Cancer (Disease Or Medical Condition)
  5. Estrogen Receptor
  6. Cancer (Disease Or Medical Condition)
Рекомендации по теме
Frontline Treatment of 0:05:51

Frontline Treatment of ER-Positive Breast Cancer

Frontline Therapy in 0:04:15

Frontline Therapy in Metastatic Breast Cancer

The use of 0:02:11

The use of frontline CDK4/6 inhibitors + endocrine therapy in metastatic breast cancer

Frontline T-DM1 in 0:03:58

Frontline T-DM1 in HER2-Positive Metastatic Breast Cancer

First-Line Treatment of 0:06:08

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

Treatment for Early-Stage 0:07:04

Treatment for Early-Stage ER+ Breast Cancer

Fitting T-DM1 Into 0:04:26

Fitting T-DM1 Into Established Upfront Treatment Paradigms

First-Line ER-Positive Metastatic 0:05:32

First-Line ER-Positive Metastatic Breast Cancer Treatments

Managing Recurrent Metastatic 0:03:22

Managing Recurrent Metastatic ER+/HER2- Breast Cancer

Remaining questions on 0:01:12

Remaining questions on the use of frontline CDK4/6 inhibitors + endocrine therapy

Estrogen positive breast 0:02:00

Estrogen positive breast cancer study

Considering Treatment for 0:02:27

Considering Treatment for HER2-Negative Breast Cancer

Palbociclib: An Exciting 0:01:59

Palbociclib: An Exciting New Option in Breast Cancer

The Ongoing Role 0:07:02

The Ongoing Role of Everolimus in ER-Positive MBC

Dr. Tripathy on 0:02:13

Dr. Tripathy on Frontline Endocrine Therapies in HR+ Breast Cancer

Factors in Deciding 0:05:06

Factors in Deciding Treatment for HR+ Breast Cancer

Overcoming resistance to 0:01:08

Overcoming resistance to CDK4/6 inhibitors in ER+ breast cancer via ctDNA

CDK 4/6 Inhibitors 0:02:19

CDK 4/6 Inhibitors for Patients with Recurrent ER+/HER2- Breast Cancer: 2023 Best of Breast

Treatment Options for 0:04:12

Treatment Options for HER2-Negative Breast Cancer

Metastatic Hormone Positive 0:26:08

Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference

Abemaciclib With Endocrine 0:06:32

Abemaciclib With Endocrine as Frontline Therapy

Upfront Treatment of 0:07:00

Upfront Treatment of HR-Positive Metastatic Breast Cancer

First-Line Treatment of 0:08:40

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

Improving the Management 0:07:03

Improving the Management of Metastatic Breast Cancer: Novel and Emerging Treatments, Part I